|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3B
|
|
pubmed:dateCreated |
2005-9-14
|
|
pubmed:abstractText |
Determination of Her-2/neu overexpression in breast cancer has previously been shown to be of prognostic significance. In this study, Her-2/neu expression in breast cancer was characterised by real-time PCR (RLT-PCR) based LightCycler-HER-2/neu DNA Quantification with immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
pubmed-author:AydenizBB,
pubmed-author:BenöhrPP,
pubmed-author:ClareS ESE,
pubmed-author:HenkelVV,
pubmed-author:KurekRR,
pubmed-author:NeubauerHH,
pubmed-author:ReiserAA,
pubmed-author:SotlarKK,
pubmed-author:SpeerRR,
pubmed-author:TabitiKK,
pubmed-author:VogelUU,
pubmed-author:WallwienerDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1895-900
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16158923-Breast Neoplasms,
pubmed-meshheading:16158923-Carcinoma, Ductal, Breast,
pubmed-meshheading:16158923-Carcinoma, Lobular,
pubmed-meshheading:16158923-Gene Amplification,
pubmed-meshheading:16158923-Gene Expression,
pubmed-meshheading:16158923-Humans,
pubmed-meshheading:16158923-Immunohistochemistry,
pubmed-meshheading:16158923-In Situ Hybridization, Fluorescence,
pubmed-meshheading:16158923-Polymerase Chain Reaction,
pubmed-meshheading:16158923-Receptor, erbB-2
|
|
pubmed:articleTitle |
Her-2/neu expression in breast cancer--A comparison of different diagnostic methods.
|
|
pubmed:affiliation |
Department of Nephrology and Rheumatology, University of Göttingen, Germany. pbenoeh@gwdg.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
